Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine-controlled trial of rupatadine fumarate in allergic rhinitis
CTR20132278Phase 2Active
- Sponsor
- Beijing Jiashi Lianbo Pharmaceutical Technology
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rupatadine in allergic rhinitis (AR), sponsored by Beijing Jiashi Lianbo Pharmaceutical Technology. Started Mar 2015; status: active.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20132278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132278.